Drug that copies gila monster venom helps diabetics lower blood sugar

06/7/2004 | Wall Street Journal, The

Amylin Pharmaceuticals and Eli Lilly, joint developers of Exenatide, reported to the American Diabetes Association meeting that their drug copied from the venom of gila monsters helps diabetics lower their blood sugar and lose weight. If successful, the drug would be the first in a new class of incretin mimetics drugs for treating Type 2 diabetes.

View Full Article in:

Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Corporate Counsel - Regulatory Law
Regeneron
Tarrytown, NY
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Active Implantable Medical Device (AIMD) Product Expert
BSI
Nationwide, SL_Nationwide
Finance Manager - ENT
Medtronic
Jacksonville, FL
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA